Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051686
Filing Date
2020-11-06
Accepted
2020-11-06 08:33:54
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-10q_20200930.htm   iXBRL 10-Q 1698920
2 EX-31.1 crnx-ex311_7.htm EX-31.1 21625
3 EX-31.2 crnx-ex312_6.htm EX-31.2 21578
4 EX-32.1 crnx-ex321_8.htm EX-32.1 6936
  Complete submission text file 0001564590-20-051686.txt   6163821

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crnx-20200930.xsd EX-101.SCH 37864
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crnx-20200930_cal.xml EX-101.CAL 41333
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crnx-20200930_def.xml EX-101.DEF 107578
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20200930_lab.xml EX-101.LAB 335387
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20200930_pre.xml EX-101.PRE 240641
10 EXTRACTED XBRL INSTANCE DOCUMENT crnx-10q_20200930_htm.xml XML 1177797
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 201292527
SIC: 2834 Pharmaceutical Preparations